1. Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring

   • K. Kubota
   • G. L. Pearce
   • W. H. W. Inman

   Pharmacoepidemiology and Prescription Pages: 1 - 7

2. Androgenic anabolic steroid use among male adolescents in Falkenberg

   • S. Nilsson

   Pharmacoepidemiology and Prescription Pages: 9 - 11

3. A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease

   • A. Grove
   • B. J. Lipworth
   • D. P. Dhillon

   Pharmacodynamics Pages: 13 - 18

4. Oral clonidine in patients with asthma: no significant effect on airway reactivity

   • J. W. Foxworth
   • G. R. Reisz
   • S. M. Knudson

   Pharmacodynamics Pages: 19 - 22

5. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma

   • S. D. Gunn
   • J. G. Ayres
   • S. M. McConchie

   Pharmacodynamics Pages: 23 - 28

6. Muscle cramps and elevated serum creatine phosphokinase levels induced by β-adrenoceptor blockers

   • Y. Imai
   • N. Watanabe
   • H. Sekino

   Pharmacodynamics Pages: 29 - 34

7. Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6

   • J. A. Hasler
   • I. Johansson
   • C. M. Masimirembwa

   Pharmacodynamics Pages: 35 - 38

8. Aminoglycosides: single or multiple daily dosing?

   • A. M. Galløe
   • N. Graudal
   • J. P. Kampmann

   Pharmacodynamics Pages: 39 - 43

9. Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazem

   • O. E. Della Paschoa
   • V. Luckow
   • S. R. C. J. Santos

   Clinical Trials Pages: 45 - 49

10. Estimation of the absolute bioavailability of flecainide using stable isotope technique

    • K. Hage
    • C. Fischer
    • K. Bühl

    Pharmacoepidemiology and Disposition Pages: 51 - 55

11. Elimination of amrinone during continuous veno-venous haemofiltration after cardiac surgery

    • A. Hellinger
    • K. Wolter
    • E. Fritschka

    Pharmacoepidemiology and Disposition Pages: 57 - 59

12. Interaction between valproate formulation and phenytoin concentrations

    • Y. Suzuki
    • T. Nagai
    • S. Okada

    Pharmacoepidemiology and Disposition Pages: 61 - 63

13. Paracetamol disposition in Thai patients during and after treatment of falciparum malaria

    • S. Ismail
    • D. J. Back
    • J. Karbwang

    Pharmacoepidemiology and Disposition Pages: 65 - 69

14. Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant

    • E. Lunell
    • L. Molander
    • M. Andersson

    Pharmacoepidemiology and Disposition Pages: 71 - 75

15. Radiation recall in a patient with breast cancer treated for tuberculosis

    • M. Extermann
    • N. Vogt
    • M. Forni

    Letter to the Editors Pages: 77 - 78

16. The acetylation phenotype: does it contribute to the non-linearity of the metabolite pharmacokinetics of metamizol?

    • N. Bacracheva
    • V. Vlahov

    Letter to the Editors Pages: 79 - 80

17. Pulmonary hypertension and dexfenfluramine

    • P. Cacoub
    • J. C. Piette
    • J. P. Houppe

    Letter to the Editors Pages: 81 - 83

18. Commentary on interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity

    • H. L. McLeod

    Letter to the Editors Pages: 85 - 86

19. Reply to Dr. McLeod's commentary on interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity

    • R. Capdeville
    • B. Mousson
    • G. Bax

    Letter to the Editors Pages: 87 - 88

20. Announcements

    Announcement Pages: 89 - 89